Patents by Inventor Ying Leng

Ying Leng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THYROID HORMONE RECEPTOR b SELECTIVE AGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF
    Publication number: 20240059676
    Abstract: The present invention relates to a thyroid hormone receptor ? selective agonist compound represented by formula I, a pharmaceutical composition and use thereof. The compound improves the selectivity to THR-? and the druggability of the compound while maintaining good THR-? agonistic activity, and shows a certain activity in in vivo pharmacological experiments.
    Type: Application
    Filed: December 10, 2021
    Publication date: February 22, 2024
    Inventors: Bing Zhou, Ying Leng, Yaxi Yang, Mengmeng Ning, Liuyu Hu, Lei Feng, Ju Liang
  • Heptacyclic compounds and the pharmaceutical uses thereof for preventing and treating diabetes and metabolic syndrome
    Patent number: 8158623
    Abstract: The invention discloses a new use of a class of heptacyclic compounds in the preparation of formulations for the prevention and treatment of diabetes and metabolic syndromes; the present invention also discloses a new class of heptacyclic compounds; the present invention also discloses a process for preparing the heptacyclic compounds and a composition containing the same. The heptacyclic compounds of the present invention can be used to effectively preventing or treating diseases such as diabetes and metabolic syndromes.
    Type: Grant
    Filed: May 29, 2007
    Date of Patent: April 17, 2012
    Assignee: Shanghai Institute of Materia Medica Chinese Academy of Sciences
    Inventors: Jianhua Shen, Ying Leng, Hualiang Jiang, Junhua Chen
  • HEPTACYCLIC COMPOUNDS AND THE PHARMACEUTICAL USES THEREOF FOR PREVENTING AND TREATING DIABETES AND METABOLIC SYNDROME
    Publication number: 20100173905
    Abstract: The invention discloses a new use of a class of heptacyclic compounds in the preparation of formulations for the prevention and treatment of diabetes and metabolic syndromes; the present invention also discloses a new class of heptacyclic compounds; the present invention also discloses a process for preparing the heptacyclic compounds and a composition containing the same. The heptacyclic compounds of the present invention can be used to effectively preventing or treating diseases such as diabetes and metabolic syndromes.
    Type: Application
    Filed: May 29, 2007
    Publication date: July 8, 2010
    Inventors: Jianhua Shen, Ying Leng, Hualiang Jiang, Junhua Chen